Research progress on auricular plaster therapy for hypertension and related commonly seen symptoms / 国际中医中药杂志

This paper reviews the clinical research literature of auricular plaster therapy for hypertension and related commonly seen symptoms. In clinic, auricular plaster therapy combined with orally taking Chinese and Western medicine, acupoint massage, ear point bloodletting and other auxiliary therapies can lower blood pressure and improve symptoms such as dizziness, headache, forgetfulness and insomnia. Auricular plaster therapy shows significant effect in the early treatment stage of essential hypertension; for patients with sleep disorders, auricular plaster therapy can increase sleep time and improve sleep quality without changing their normal sleep mode; for patients with depression or anxiety disorder, auricular plaster therapy shows significant effect in the short-term is, but when stop the intervention, it’s not that effective in the long term, and the antihypertensive and antidepressant effects disappear quickly. The main acupoint selection of auricular plaster therapy is relatively fixed, and the manipulation is roughly the same, which is easy to be popularized.

Performance verification of Hitachi 7600-210 automatic biochemical analyzer detection system to glucose detection / 国际检验医学杂志

Objective To verify the analytical performance of Hitachi 7600-210automatic biochemical analyzer detection system.Methods The precision, accuracy, linearity and clinical reportable range, limit of quantitative detection and anti-interference capability were validated according to Clinical and Laboratory Standards Institute (CLSI) documents (EP15-A3and EP17-A2) and Clinical Laboratory Improvement Amendment 1988 (CLIA′88) standards.Results The within precisions of high and low two concentrations were both less than1/4CLIA′88TEa (laboratory permissible total error), the day precisions were less than 1/3CLIA′88TEa, the pass rates of three external quality assessments in 2017 were all not less than 80％and range from 0.02mmol/L to 401.80mmol/L.The clinical reportable was ranged from 0.02to 401.80mmol/L with a linear relationship.The LoB, LoD and LoQ of glucose (GLU) detection were 0.01 mmol/L, 0.03 mmol/L and 0.08mmol/L respectively.The anti-interference capability to hemoglobin (Hb), vitamin C (VitC), bilirubin (BIL) and triglyceride (TG) in the detection system to GLU measurement were in accordance with the manufacturer′s statement.Conclusion Performance verification of Hitachi 7600-210automatic biochemical analyzer detection system to GLU detection is consistent with the manufacturer statement also in accordance with CLIA′88standards, which can meet the expectant use of clinical test.